Skip to main content

CONAN II - COmplete Nucleic acid ANalysis at genome scale at ultra-high throughput Phase 2

Project description

A revolutionary technology for genetic and epigenetic data analysis

Epigenetic modifications play vital roles in biology, from early embryonic development to defence mechanisms and cancer. However, current sequencing technologies fail to read the majority of these modifications. To address this limitation, the scientists of the EU-funded CONAN II project have developed the single-molecule magnetic detection and quantification (SIMDEQ) proprietary technology that in addition to genetic data it can read the chemical signatures on both DNA and RNA. During the CONAN II project, scientists developed a fully functional high-throughput system suitable for commercialisation. The SIMDEQ technology fosters a new genomics approach and has the potential to revolutionise genetic and epigenetic analysis studies.

Call for proposal


See other projects for this call

Sub call



Net EU contribution
€ 2 046 320,50
3-5 Impasse Reille
75014 Paris

See on map

Ile-de-France Ile-de-France Paris
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 876 994,50